Related Experiment Video

Updated: May 19, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Meticillin-resistant Staphylococcus aureus pneumonia

B Edwards1, Im Gould

  • 1Department of Medical Microbiology, Southern General Hospital, Glasgow, UK. bex.edwards@gmail.com

British Journal of Hospital Medicine (London, England : 2005)
|August 10, 2012
PubMed

Insights

Meticillin-resistant Staphylococcus aureus (MRSA) causes diverse pneumonia presentations. Differentiating healthcare-associated from community-associated infections is vital for effective treatment strategies.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Meticillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen causing pneumonia.
  • Clinical presentations of MRSA pneumonia are diverse and evolving.
  • Distinguishing healthcare-acquired infections from community-associated infections is critical.

Purpose of the Study:

  • To analyze the evolving clinical spectrum of MRSA pneumonia.
  • To highlight the differences between healthcare-acquired and community-associated MRSA pneumonia.
  • To emphasize the need for updated management strategies.

Main Methods:

  • Review of clinical data and microbiological findings.
  • Comparative analysis of patient populations and outcomes.
  • Literature synthesis on current treatment guidelines and emerging challenges.

Main Results:

  • MRSA pneumonia exhibits varied clinical manifestations.
  • Healthcare-acquired MRSA pneumonia presents distinct epidemiological and clinical features compared to community-associated disease.
  • Current antibiotic regimens show limitations in treating MRSA pneumonia.

Conclusions:

  • Effective management of MRSA pneumonia requires careful consideration of its origin (healthcare-associated vs. community-associated).
  • There is an urgent need for novel therapeutic approaches and comprehensive management strategies to combat MRSA.
  • Clinicians must remain vigilant to prevent complacency in treating this evolving infectious threat.

More Related Videos

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...